A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Clinical trial NCT07247110 · RECRUITING

Trial details

NCT number: NCT07247110
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2025-12-16
Primary completion: 2030-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.